{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:39:49Z","timestamp":1775608789950,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jdcr.2024.06.002","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T21:14:21Z","timestamp":1718399661000},"page":"38-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Cabozantinib-associated acquired perforating dermatosis"],"prefix":"10.1016","volume":"52","author":[{"given":"Denis","family":"Smirnov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hillary","family":"Tsibris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.jdcr.2024.06.002_bib1","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1510016","article-title":"Cabozantinib versus everolimus in advanced renal-cell carcinoma","volume":"373","author":"Choueiri","year":"2015","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jdcr.2024.06.002_bib2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jaad.2019.04.021","article-title":"Risk of hand-foot skin reaction associated with vascular endothelial growth factor-tyrosine kinase inhibitors: a meta-analysis of 57 randomized controlled trials involving 24,956 patients","volume":"83","author":"Ding","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jdcr.2024.06.002_bib3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0190-9622(84)80259-5","article-title":"The perforating disorders","volume":"10","author":"Patterson","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdcr.2024.06.002_bib4","series-title":"Fitzpatrick\u2019s Dermatology","article-title":"Acquired perforating disorders","author":"Desman","year":"2019"},{"issue":"7","key":"10.1016\/j.jdcr.2024.06.002_bib5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/DAD.0b013e31828cf3b7","article-title":"Perforating folliculitis in a patient treated with nilotinib: a further evidence of C-kit involvement","volume":"36","author":"Llamas-Velasco","year":"2014","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"10.1016\/j.jdcr.2024.06.002_bib6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.4103\/idoj.IDOJ_592_19","article-title":"Dasatinib-induced perforating folliculitis in a bone marrow transplant patient","volume":"11","author":"Prabhakaran","year":"2020","journal-title":"Indian Dermatol Online J"},{"issue":"2","key":"10.1016\/j.jdcr.2024.06.002_bib7","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2340\/00015555-1248","article-title":"Reactive perforating collagenosis during erlotinib therapy","volume":"92","author":"Suzuki","year":"2012","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.jdcr.2024.06.002_bib8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/jdv.12720","article-title":"Acquired perforating dermatosis associated with sorafenib therapy","volume":"30","author":"Severino-Freire","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.jdcr.2024.06.002_bib9","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1346-8138.2010.00885.x","article-title":"Transient perforating folliculitis induced by sorafenib","volume":"37","author":"Minami-Hori","year":"2010","journal-title":"J Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512624002170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512624002170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:24:42Z","timestamp":1741220682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512624002170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":9,"alternative-id":["S2352512624002170"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2024.06.002","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cabozantinib-associated acquired perforating dermatosis","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2024.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}